| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |